Clinical Trial

Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated July 23, 2025 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The current postoperative cataract surgery eye drop regimen used at Zuckerberg San Francisco General Hospital (ZSFG) is a significant burden for its patient population, contributing to high rates of non-adherence and the development of postoperative complications. The investigators propose to replace this complex regimen with a single administration of intraocular antibiotic and subconjunctival steroid at the time of surgery. This pilot study will obtain the preliminary data required to eventually fully evaluate this innovation in postoperative care in a safety-net population with respect to postoperative outcomes, patient compliance, and patient and caregiver satisfaction.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2021-11-30; most recent amendment 2025-07-18.
Status change: Not Yet Recruiting → Recruiting 2022-05-31
Trial Details
NCT Number NCT05157113
Lead Sponsor University of California, San Francisco
Conditions Cataract, Surgery, Compliance, Patient, Compliance, Medication, Satisfaction, Patient
Enrollment 70 participants
Start Date 2022-05-31
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-23